Minerva Neurosciences Other Long Term Assets (Quarterly) Insights

Minerva Neurosciences, Inc. (NERV)

3.79 -0.40 (-9.55%) USD | NASDAQ | Jan 22, 12:38

View Other Long Term Assets (Quarterly) for NERV.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Assets (Quarterly) Benchmarks

Start Trial

iBio, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	--